Evidence map›Paper›PMID 35361499›Full record

ReviewTrends in neurosciences2022

Insulin action in the brain: cell types, circuits, and diseases.

Wenqiang Chen, Weikang Cai, Benjamin Hoover, C Ronald Kahn

Open access · greenAbstract readReview
In one paragraph

Review in Trends in neurosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 3 pooled it
30.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 3 syntheses or guidelines pooled it, 145 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Distinct single-nucleus RNA-seq changes among non-neuronal cells in ADNC, LATE-NC, and mixed pathologies.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. [Research progress in mechanisms of dietary resistant starch for regulating glucose and lipid metabolism].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Wenqiang ChenSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02115, USA.
Weikang CaiSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02115, USA; Department of Biomedical Sciences, College of Osteopathic Medicine, New York Institute of Technology, Old Westbury, NY 11568, USA.
Benjamin HooverSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02115, USA; Massachusetts General Hospital, Boston, MA 02114, USA.
C Ronald KahnSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Harvard Medical School, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA. Electronic address: c.ronald.kahn@joslin.harvard.edu.
Harvard University · USJoslin Diabetes Center · USMassachusetts General Hospital · US

Funding

The Insulin Receptor and Its Signaling MechanismsR01DK031036 · NIDDK · JOSLIN DIABETES CENTER · PI C RONALD KAHN · 1986 to 2026
$4.2M
Alterations in Post-Receptor Insulin Signaling in Diabetes and Insulin ResistanceR01DK128429 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 2021 to 2025
$2.9M
Astrocyte-derived signals for neuronal and behavioral modulation and its implications in mental illness.R01MH125903 · NIMH · UNIVERSITY OF KENTUCKY · PI CAI, WEIKANG · 2021 to 2025
$1.6M
Regulation of neural function by astrocyte insulin and IGF-1 receptor signalingK01DK120740 · NIDDK · NEW YORK INST OF TECHNOLOGY · PI CAI, WEIKANG · 2019 to 2021
$439k
NIDDK NIH HHS K01 DK120740NIDDK NIH HHS R01 DK031036NIDDK NIH HHS R01 DK128429NIMH NIH HHS R01 MH125903
6 · The paper itself

Abstract

Since its discovery over 100 years ago, insulin has been recognized as a key hormone in control of glucose homeostasis. Deficiencies of insulin signaling are central to diabetes and many other disorders. The brain is among the targets of insulin action, and insulin resistance is a major contributor to many diseases, including brain disorders. Here, we summarize key roles of insulin action in the brain and how this involves different brain cell types. Disordered brain insulin signaling can also contribute to neuropsychiatric diseases, affecting brain circuits involved in mood and cognition. Understanding of insulin signaling in different brain cell types/circuits and how these are altered in disease may lead to the development of new therapeutic approaches to these challenging disorders.

Indexed as

Alzheimer DiseaseInsulin ResistanceBrainCentral Nervous SystemHomeostasisHumansInsulinInsulinAlzheimer’s diseasesastrocytesdepressiondiabetesinsulin resistanceneurons

Identifiers

PMID35361499
PMCPMC9035105
OpenAlexW4220855612

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.